Strata Skin Sciences Return on Tangible Equity 2010-2025 | SSKN

Current and historical return on tangible equity values for Strata Skin Sciences (SSKN) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Strata Skin Sciences Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $-0.01B $-0.01B 228.57%
2024-12-31 $-0.01B $0.00B 276.92%
2024-09-30 $-0.01B $0.00B 327.27%
2024-06-30 $-0.01B $0.00B 320.00%
2024-03-31 $-0.01B $0.00B 293.33%
2023-12-31 $-0.01B $0.00B 258.82%
2023-09-30 $-0.01B $0.00B 140.00%
2023-06-30 $-0.01B $-0.01B 121.74%
2023-03-31 $-0.01B $-0.01B 120.00%
2022-12-31 $-0.01B $0.00B 126.32%
2022-09-30 $-0.01B $-0.01B 350.00%
2022-06-30 $-0.01B $-0.01B -700.00%
2022-03-31 $0.00B $-0.01B -80.00%
2021-12-31 $0.00B $0.01B -35.29%
2021-09-30 $0.00B $0.01B -21.05%
2021-06-30 $0.00B $0.01B -19.51%
2021-03-31 $-0.01B $0.01B -48.78%
2020-12-31 $0.00B $0.01B -36.36%
2020-09-30 $-0.01B $0.01B -44.44%
2020-06-30 $-0.01B $0.01B -42.55%
2020-03-31 $0.00B $0.01B -33.33%
2019-12-31 $0.00B $0.01B -33.33%
2019-09-30 $0.00B $0.01B -24.49%
2019-06-30 $0.00B $0.01B -23.08%
2019-03-31 $0.00B $0.01B -22.22%
2018-12-31 $0.00B $0.01B -38.10%
2018-09-30 $-0.01B $0.02B -114.29%
2018-06-30 $-0.02B $0.01B -525.00%
2018-03-31 $-0.02B $0.00B 1050.00%
2017-12-31 $-0.02B $0.00B 466.67%
2017-09-30 $-0.02B $0.00B 300.00%
2017-06-30 $-0.01B $-0.01B 70.59%
2017-03-31 $-0.01B $-0.01B 66.67%
2016-12-31 $0.00B $-0.01B 55.17%
2016-09-30 $0.00B $-0.01B 53.33%
2016-06-30 $-0.01B $-0.01B 175.00%
2016-03-31 $-0.02B $-0.01B 366.67%
2015-12-31 $-0.03B $-0.01B 1600.00%
2015-09-30 $-0.03B $-0.01B -1015.38%
2015-06-30 $-0.02B $0.00B -248.65%
2015-03-31 $-0.01B $0.01B -133.33%
2014-12-31 $-0.02B $0.01B -150.00%
2014-09-30 $-0.01B $0.02B -155.56%
2014-06-30 $-0.02B $0.01B -245.16%
2014-03-31 $-0.03B $0.01B -263.41%
2013-12-31 $-0.03B $0.01B -179.31%
2013-09-30 $-0.03B $0.01B -168.75%
2013-06-30 $-0.03B $0.02B -138.89%
2013-03-31 $-0.02B $0.02B -124.32%
2012-12-31 $-0.02B $0.01B -117.33%
2012-09-30 $-0.02B $0.02B -92.31%
2012-06-30 $-0.02B $0.02B -95.65%
2012-03-31 $-0.02B $0.02B -91.67%
2011-12-31 $-0.02B $0.03B -84.85%
2011-09-30 $-0.02B $0.02B -83.17%
2011-06-30 $-0.02B $0.02B -67.23%
2011-03-31 $-0.02B $0.03B -65.57%
2010-12-31 $-0.02B $0.03B -63.49%
2010-09-30 $-0.02B $0.04B -67.74%
2010-06-30 $-0.02B $0.03B -75.00%
2010-03-31 $-0.02B $0.03B -85.11%
2009-12-31 $-0.02B $0.03B -102.70%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.008B $0.034B
Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.855B 58.34
Tempus AI (TEM) United States $12.818B 0.00
Doximity (DOCS) United States $12.199B 54.28
Hims & Hers Health (HIMS) United States $10.401B 85.22
IRhythm Technologies (IRTC) United States $5.159B 0.00
Hinge Health (HNGE) United States $4.608B 0.00
Privia Health (PRVA) United States $2.610B 193.36
Inspire Medical Systems (INSP) United States $2.596B 38.16
Heartflow (HTFL) $2.530B 0.00
Phreesia (PHR) United States $1.708B 0.00
Enovis (ENOV) United States $1.689B 8.93
10x Genomics (TXG) United States $1.663B 0.00
Omnicell (OMCL) United States $1.456B 28.04
Schrodinger (SDGR) United States $1.426B 0.00
Azenta (AZTA) United States $1.393B 60.78
Clover Health Investments (CLOV) United States $1.358B 0.00
Claritev (CTEV) United States $1.180B 0.00
Evolent Health (EVH) United States $1.092B 0.00
Fulgent Genetics (FLGT) United States $0.651B 0.00
Veradigm (MDRX) United States $0.498B 0.00
Zepp Health (ZEPP) Netherlands $0.491B 0.00
Standard BioTools (LAB) United States $0.467B 0.00
Talkspace (TALK) United States $0.429B 128.00
Carlsmed (CARL) $0.360B 0.00
Butterfly Network (BFLY) United States $0.360B 0.00
TruBridge (TBRG) United States $0.289B 50.74
Outset Medical (OM) United States $0.236B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.235B 0.00
Nyxoah SA (NYXH) Belgium $0.212B 0.00
Health Catalyst (HCAT) United States $0.205B 0.00
KORU Medical Systems (KRMD) United States $0.193B 0.00
CapsoVision (CV) United States $0.178B 0.00
MDxHealth SA (MDXH) Belgium $0.135B 0.00
American Well (AMWL) United States $0.115B 0.00
CareCloud (CCLD) United States $0.110B 5.00
EUDA Health Holdings (EUDA) Singapore $0.094B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.092B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.069B 0.00
Pulmonx (LUNG) United States $0.064B 0.00
111 (YI) China $0.058B 0.00
P3 Health Partners (PIII) United States $0.049B 0.00
HeartBeam (BEAT) United States $0.035B 0.00
Precipio (PRPO) United States $0.024B 0.00
Healthcare Triangle (HCTI) United States $0.023B 0.00
Zhongchao (ZCMD) China $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
MSP Recovery (MSPR) United States $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
PROFUSA (PFSA) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00